AeroVironment Faces Securities Fraud Lawsuit Following SCAR Contract Cancellation

What happened

A class action lawsuit has been filed against AeroVironment alleging securities fraud after the company's stock dropped 17% following the cancellation of the SCAR contract. The lawsuit, announced by Bleichmar Fonti & Auld LLP, claims that AeroVironment and senior executives violated federal securities laws by making misleading statements about the contract. This development compounds existing challenges: the SCAR termination caused a $240.7 million goodwill impairment and the company has been grappling with material weaknesses in internal controls. The growth story relies on converting a $1.18 billion funded backlog and new counter-UAS awards, but execution and credibility remain unproven. The litigation introduces additional uncertainty around management focus and could lead to settlement costs or reputational damage.

Implication

The class action lawsuit introduces a new layer of risk, potentially distracting management and leading to financial penalties or settlements. While the master report already reflected a cautious WAIT rating due to control weaknesses and SCAR-related impairment, the legal action increases the probability of the bear case scenario, where the stock could drift toward $135 or lower. Investors should monitor the lawsuit's progress closely; a dismissal would be a positive catalyst, while continued discovery could reveal further problems. The operational milestones—backlog conversion, margin improvement, and control remediation—remain the primary drivers, but legal overhang may weigh on the stock regardless of fundamentals. Given the current price near $158, the risk-reward is not favorable, and investors should wait for a resolution or a deeper discount.

Thesis delta

The existing thesis already incorporated SCAR cancellation risk and control weaknesses, but the class action lawsuit represents an incremental negative that directly challenges management's credibility and could impose material costs. This shift increases the likelihood that the stock will test the bear case valuation of $135 near-term, as litigation risk often overhangs stocks until clarity emerges. The fundamental checkpoints remain important, but the legal overhang now requires a higher margin of safety before buying.